FDA Avoided Half Of ANDA Pre-Approval Inspections During COVID By Using Alternative Tools

 
• By Derrick Gingery

Records reviews are common now in lieu of an in-person inspection for US generic applications, but more virtual facility checks could be coming soon.

Files under review
Previous four fiscal quarters showed a more than 50% reduction in the PAI inspections that were needed. • Source: Alamy

More from R&D

More from Pink Sheet